Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

37
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
37
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

42
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
42
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Changes in Cardiac-Arterial Coupling After Cardiac Surgery for Aortic Valve Disease.

Reviews in cardiovascular medicine·2026
Same author

QTc Interval Prolongation and Associated Drug Therapy in Hospitalized Older Adults.

Journal of the American Geriatrics Society·2026
Same author

Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition : A Systematic Review.

Annals of internal medicine·2026
Same author

Hospital Frailty Risk Score Predicts Long-Term Hospital Readmissions in Very Old Patients with Heart Failure.

Journal of clinical medicine·2026
Same author

European Working Group on Sarcopenia in Older People Algorithm: Step-by-Step Relation With Length of Hospitalization.

Journal of the American Geriatrics Society·2026
Same author

Adipocytes in Aortic Stenosis: Association With Clinical and Morphological Indices.

Clinical anatomy (New York, N.Y.)·2025

相关实验视频

Updated: Sep 9, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.4K

如何有效治疗老年人的高血压?

Francesco Fantin, Anna Giani, Elena Zoico

    Polish archives of internal medicine
    |September 4, 2025
    PubMed
    概括

    在老年人中治疗高血压需要个性化治疗. 降低血压的好处适合个人,但脆弱的老年患者需要谨慎治疗,以避免伤害和保持独立.

    科学领域:

    • 老年学
    • 心脏病学
    • 临床药理学

    背景情况:

    • 高血压是老年人群的主要心血管风险因素,与血管老化和并发症有关.
    • 控制老年人的血压, 尤其是脆弱的, 呈现出复杂的利益风险平衡.
    • 由于高血压与认知障碍和脏疾病有关,对老年人进行高血压治疗至关重要.

    研究的目的:

    • 综合有关老年人高血压的当前知识,重点关注病理生理学,流行病学和治疗.
    • 强调基于脆弱性和功能状态的个性化治疗策略.
    • 对健康和脆弱的老年人血压管理的证据进行审查.

    主要方法:

    • 对国际指导方针 (ESC,ESH),临床试验和现实研究进行叙述性审查.
    • 随机对照试验和观察性研究的聚焦分析.
    • 包括对不同老年人小组高血压治疗的风险和益处的研究.

    主要成果:

    • 降低血压对健康的老年人 (例如HYVET,SPRINT-SENIOR) 的心血管结果有好处.
    • 在虚弱或住院的老年患者中,过度治疗会带来跌倒和死亡率增加等风险 (例如,PARTAGE,OPTiMiSE).
    • 在这种人群中,正静性低血压,功能障碍和多药性复杂化高血压的管理.

    更多相关视频

    Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
    05:57

    Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

    Published on: May 17, 2024

    845
    Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
    12:59

    Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

    Published on: July 5, 2017

    12.7K

    相关实验视频

    Last Updated: Sep 9, 2025

    Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
    08:35

    Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

    Published on: May 26, 2022

    3.4K
    Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
    05:57

    Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

    Published on: May 17, 2024

    845
    Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
    12:59

    Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

    Published on: July 5, 2017

    12.7K

    结论:

    • 老年人高血压管理需要个性化方法, 综合老年评估和虚弱评估.
    • 以患者为中心的目标对于量身定制治疗强度至关重要,平衡心血管保护与安全,认知和功能独立.
    • 未来的研究应优先考虑包括较脆弱的老年人群,以完善临床决策.